Papadaki HA - Search Results

1

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries.

Liapis K, Papadopoulos V, Pontikoglou C, Vrachiolias G, Stavroulaki E, Kourakli A, Lazaris V, Galanopoulos AG, Papoutselis M, Papageorgiou SG, Diamantopoulos PT, Pappa V, Viniou NA, Τsokanas D, Vassilakopoulos TP, Hatzimichael E, Bouronikou E, Ximeri M, Megalakaki A, Zikos P, Panayiotidis P, Dimou M, Karakatsanis S, Papaioannou M, Papadakis S, Vardi A, Kontopidou F, Harchalakis N, Adamopoulos I, Symeonidis A, Papadaki HA, Kotsianidis I. Liapis K, et al. Among authors: papadaki ha. Leukemia. 2023 Mar;37(3):708-711. doi: 10.1038/s41375-023-01819-x. Epub 2023 Jan 16. Leukemia. 2023. PMID: 36646886 No abstract available.

2

High prevalence of Helicobacter pylori infection and monoclonal gammopathy of undetermined significance in patients with chronic idiopathic neutropenia.

Papadaki HA, Pontikoglou C, Stavroulaki E, Minadakis G, Eliopoulos DA, Pyrovolaki K, Skordilis P, Eliopoulos GD. Papadaki HA, et al. Ann Hematol. 2005 May;84(5):317-20. doi: 10.1007/s00277-004-0996-y. Epub 2005 Feb 25. Ann Hematol. 2005. PMID: 15731921

3

Soluble c-kit ligand production by bone marrow stromal cells is independent of the degree of neutropenia in patients with chronic idiopathic neutropenia.

Papadaki HA, Pontikoglou C, Stavroulaki E, Eliopoulos DG, Mavroudi I, Spanoudakis M, Eliopoulos GD. Papadaki HA, et al. Ann Hematol. 2006 Mar;85(3):170-3. doi: 10.1007/s00277-005-0063-3. Epub 2006 Jan 4. Ann Hematol. 2006. PMID: 16391909

4

Effect of cA2 anti-tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes.

Boula A, Voulgarelis M, Giannouli S, Katrinakis G, Psyllaki M, Pontikoglou C, Markidou F, Eliopoulos GD, Papadaki HA. Boula A, et al. Among authors: papadaki ha. Clin Cancer Res. 2006 May 15;12(10):3099-108. doi: 10.1158/1078-0432.CCR-06-0254. Clin Cancer Res. 2006. PMID: 16707608 Clinical Trial.

5

Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10.

Koumaki V, Damianaki A, Ximeri M, Pontikoglou C, Axioti F, Spanoudakis M, Eliopoulos GD, Papadaki HA. Koumaki V, et al. Among authors: papadaki ha. Br J Haematol. 2006 Nov;135(4):570-3. doi: 10.1111/j.1365-2141.2006.06345.x. Epub 2006 Oct 10. Br J Haematol. 2006. PMID: 17054669 Free article.

6

Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia.

Pyrovolaki K, Mavroudi I, Papadantonakis N, Velegraki M, Ximeri M, Kalpadakis C, Gvazava G, Klaus M, Eliopoulos GD, Papadaki HA. Pyrovolaki K, et al. Among authors: papadaki ha. Eur J Haematol. 2007 Dec;79(6):531-8. doi: 10.1111/j.1600-0609.2007.00961.x. Epub 2007 Oct 23. Eur J Haematol. 2007. PMID: 17961177

7

The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.

Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HA. Eliopoulos DG, et al. Among authors: papadaki ha. Eur J Haematol. 2009 Dec 1;83(6):535-40. doi: 10.1111/j.1600-0609.2009.01319.x. Epub 2009 Jul 14. Eur J Haematol. 2009. PMID: 19614955

8

Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.

Ximeri M, Galanopoulos A, Klaus M, Parcharidou A, Giannikou K, Psyllaki M, Symeonidis A, Pappa V, Kartasis Z, Liapi D, Hatzimichael E, Kokoris S, Korkolopoulou P, Sambani C, Pontikoglou C, Papadaki HA; Hellenic MDS Study Group. Ximeri M, et al. Among authors: papadaki ha. Haematologica. 2010 Mar;95(3):406-14. doi: 10.3324/haematol.2009.010876. Epub 2009 Sep 22. Haematologica. 2010. PMID: 19773257 Free PMC article.

9

Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.

Klaus M, Stavroulaki E, Kastrinaki MC, Fragioudaki P, Giannikou K, Psyllaki M, Pontikoglou C, Tsoukatou D, Mamalaki C, Papadaki HA. Klaus M, et al. Among authors: papadaki ha. Stem Cells Dev. 2010 Jul;19(7):1043-54. doi: 10.1089/scd.2009.0286. Stem Cells Dev. 2010. PMID: 19788374

10

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

Tsagarakis NJ, Kentrou NA, Papadimitriou KA, Pagoni M, Kokkini G, Papadaki H, Pappa V, Marinakis T, Anagnostopoulos NI, Vadikolia C, Anagnostopoulos A, Angelopoulou MK, Terpos E, Poziopoulos C, Anargyrou K, Rontogianni D, Papadaki T, Psarra A, Kontopidou FN, Skoumi D, Papadhimitriou SI, Paterakis G; Hellenic Dendritic Cell Leukemia Study Group. Tsagarakis NJ, et al. Leuk Res. 2010 Apr;34(4):438-46. doi: 10.1016/j.leukres.2009.09.006. Epub 2009 Sep 29. Leuk Res. 2010. PMID: 19793612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page